Sygnis Is A German Stocklisted Company Devoted To The Development Of Novelsuperior Tools For Molecular Biology That Play Key Roles In Changing The Way Genomic And Proteomic Research Is Done Todaysygnis Specializes In The Development And Commercialization Of Proprietary Technologies And A Commercial Product Portfolio Addressing Key Challenges In Molecular Biologywith The Acquisition Of Expedeon Holdingsltdbased In Cambridgeuksygnis Has Added A Complementary Proteomic Product Portfoliowith This Significant Expansion Sygnis Portfolio Now Covers The Entire Workflow Of Molecular Biologyproducts Are Sold Through A Direct Sales Force And Distribution Partners In Europethe Us And Asia Sygnis Has Offices In Germanyspain And The Ukproduction Sites In The Uk And The Us And Sales Offices In Asiathe Company Is Listed On The German Stock Exchange In The Prime Standard Segmenttickerlio1Isinde000A1Rfm03
No conferences found for this company.
| Company Name | Sygnis Bioscience Gmbh And Co Kg |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
